FTC Top 10 Articles on GenomeWeb in 2021 The most-read stories in 2021 represents readers' vast interests in the variety of topics covered by GenomeWeb from COVID-19 tests to IPOs and legal battles. Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Caris said it has already provided materials to Illumina and should not have to indulge a "fishing expedition for irrelevant, highly sensitive details." US Federal Trade Commission Begins Making the Case for Unwinding Illumina's Grail Purchase Premium The FTC claimed that Illumina can and will disadvantage Grail's rivals, but lawyers for the companies said the merger's benefits outweigh "speculative harms." Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom Premium Illumina faces potential fines in Europe for moving ahead with the deal but felt it had to act now in order to make sure it went through at all. Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium The US Federal Trade Commission's recent challenge raises the question who Illumina can acquire while remaining a quasi-monopolist for sequencing equipment. Mar 30, 2021 FTC Moves to Block Illumina's $8B Grail Acquisition Mar 22, 2020 FDA Warns Consumers About Fraudulent At-Home COVID-19 Test Kits Jan 2, 2020 Illumina, Pacific Biosciences Abandon $1.2B Acquisition Deal Oct 23, 2019 National Council on Disability Recommends More Regulation of NIPT Jan 31, 2014 FTC Says Sale of Certain Thermo Fisher Assets to GE Healthcare is Required for Life Tech Deal OK Jan 8, 2014 FTC, GeneLink and Subsidiary Reach Deal to Settle Charges of False Advertising Jun 6, 2013 Thermo Fisher Plans Public Offering of $2.2B to Fund Life Tech Buy; Expects Another FTC Request Jan 8, 2013 Illumina Withdraws Complete Genomics Bid Jan 7, 2013 BGI Bid to Acquire Complete Genomics Passes US Antitrust Hurdle; Tender Offer Extended Again Nov 6, 2012 FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics Dec 8, 2011 LabCorp's Bid for Orchid Cellmark Finally Cleared by FTC Nov 7, 2011 LabCorp Extends Proposed Orchid Cellmark Buy Again Oct 20, 2011 PerkinElmer Acquisition of Caliper Clears Anti-Trust Review Sep 12, 2011 LabCorp Extends Offer for Orchid for Sixth Time Jun 16, 2011 LabCorp Further Extends Offer for Orchid Cellmark May 18, 2011 LabCorp Extends Tender Offer for Orchid Cellmark as FTC Requests More Information Mar 9, 2011 FTC Clears Danaher's Proposed Acquisition of Beckman Coulter Nov 18, 2010 LabCorp Buy of Genzyme Genetics Clears FTC Feb 10, 2010 Myriad Defends Policy of Urging Docs to Genetically Counsel BRACAnalysis Customers Premium Jan 22, 2010 European Commission OKs Agilent's Acquisition of Varian; FTC Approval Still Pending Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.